GECCO - Implementation Guide - Current
Home
Introduction
Transaction Bundle
Patient
Consent
GECCO Core
Anamnesis / Risk factors
Chronic lung diseases
Disorders of cardiovascular system
Chronic liver diseases
Rheumatological/immunological diseases
Human immunodeficiency virus infection
History of being a tissue or organ recipient
Diabetes mellitus
Malignant neoplastic diseases
Tobacco smoking status
Chronic neurological or mental diseases
Respiratory therapies
Chronic kidney diseases
History of travel
Gastrointestinal ulcers
Immunization status
Resuscitation status
Imaging
Imaging procedures
Radiological findings
Demographics
Pregnancy
Ethnic group
Biological sex
Date of birth
Age
Frailty score
Body weight
Body height
Epidemiological factors
Contact with persons suffering from Covid-19?
Complications
Complication
Onset of illness / Admission
Stage at diagnosis
Laboratory values
Laboratory value
SARS-CoV-2-RT-PCR
SARS-CoV-2 antibodies
Medication
Covid-19 therapy
ACE inhibitors
Immunoglobulins
Anticoagulation
Outcome at discharge
Respiratory outcome
Type of discharge
Follow-up swab result
Study enrollment / Inclusion criteria
Study enrolment due to Covid-19
Interventional studies participation
Symptoms
Symptom
Therapy
Dialysis / Hemofiltration
Apheresis
Prone position
ECMO therapy
Is the patient in the intensive care unit?
Ventilation type
Vital signs
PaCO2
PaO2
FiO2
pH
SOFA-Score
Respiratory rate
Diastolic blood pressure
Systolic blood pressure
Heart rate
Body temperature
Peripheral oxygen saturation
Terminologies
Onset of illness / Admission